EYECARE Lumenis OptiLight Wins MedTech Breakthrough Award for Best New Tech Solution for Ophthalmology By Staff Thursday, June 2, 2022 12:27 AM YOKNE’AM ILLIT, Israel—Lumenis Be. announced that its OptiLight device has received the MedTech Breakthrough Award for “Best New Technology Solution for Ophthalmology.” This year, MedTech’s range of health and medical technology categories attracted more than 3,900 nominations from over 15 countries, from which MedTech selected OptiLight. The win follows Lumenis’ MedTech awards for Best Overall Medical Device Company in 2021 and Best New Surgical Technology Solution in 2020. OptiLight is the first and only light treatment that is FDA approved for management of dry eye disease.Lumenis’ patented Optimal Pulse Technology (OPT) offers targeted, uniform, precise and controlled treatment that safely and effectively breaks the cycle of inflammation associated with dry eye disease, according to Lumenis.“Dry eye disease is highly prevalent and difficult to manage, and traditional treatments like warm compresses and artificial tears treat the symptoms but not the underlying pathology,” said James Johnson, managing director, MedTech Breakthrough. “OptiLight is leading a revolution in managing dry eye disease with ‘breakthrough’ technology that allows doctors to treat patients quickly, in-office. With broad potential for tens of millions with dry eye disease, OptiLight stands out from the crowd to become our 2022 Best New Technology Solution for Ophthalmology.”Lumenis introduced OptiLight in May 2021 and recently launched a national media campaign featuring singer-songwriter and actress Mandy Moore, from "This Is Us," to increase awareness for dry eye disease and encourage people who might be suffering from this condition to seek out a physician who offers OptiLight.“We’re grateful to MedTech for honoring OptiLight for its innovation and impact in eyecare,” said Lumenis CEO Tzipi Ozer-Armon. “Lumenis is committed to raising the bar for patients’ health by providing cutting-edge solutions and treatment innovations. As the only light-based treatment for dry eye disease, OptiLight has the power to elevate dry eye management and improve health and quality of life for millions of people around the world.”Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include patient engagement, health, health and fitness, clinical administration, health care IoT, medical data, health care cybersecurity and more.